Discontinued drugs in 2011: cardiovascular drugs.

Zhao, Hong-Ping; Jiang, Hong-Min; Xiang, Bing-Ren

Zhao, Hong-Ping; Jiang, Hong-Min; Xiang, Bing-Ren.

Afiliação

Zhao HP; China Pharmaceutical University, Center for Instrumental Analysis, Key Laboratory of Drug Quality Control & Pharmacovigilance, Ministry of Education, Nanjing, Jiangsu, People's Republic of China.

Expert Opin Investig Drugs ; 21(10): 1449-62, 2012 Oct.

Article em En | MEDLINE | ID: mdl-22827213

ABSTRACT

ABSTRACT

This perspective is part of an annual series of papers discussing drugs dropped from development in the previous year. Specifically, this paper focuses on the 19 cardiovascular drugs discontinued in 2011 after reaching preclinical or Phase I - III clinical trials. Information for this perspective is mainly derived from a search of Pharmaprojects.

Assuntos

Fármacos Cardiovasculares; Aprovação de Drogas; Drogas em Investigação; Fármacos Cardiovasculares/uso terapêutico; Ensaios Clínicos como Assunto; Drogas em Investigação/uso terapêutico; Humanos

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Cardiovasculares / Drogas em Investigação / Aprovação de Drogas Limite: Humans Idioma: En Revista: Expert Opin Investig Drugs Assunto da revista: TERAPIA POR MEDICAMENTOS Ano de publicação: 2012 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links